Patents by Inventor Alessandro Lamonica

Alessandro Lamonica has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline beta-lactamase inhibitor
    Patent number: 11124526
    Abstract: A crystalline compound of formula (I): The compound of formula (I) is a ?-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: September 21, 2021
    Assignee: Allecra Therapeutics SAS
    Inventors: Alessandro Lamonica, Marco Forzatti, Stefano Biondi
  • CRYSTALLINE BETA-LACTAMASE INHIBITOR
    Publication number: 20190071456
    Abstract: A crystalline compound of formula (I): The compound of formula (I) is a ?-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
    Type: Application
    Filed: October 31, 2018
    Publication date: March 7, 2019
    Applicant: Allecra Therapeutics SAS
    Inventors: Alessandro Lamonica, Marco Forzatti, Stefano Biondi
  • Crystalline Beta-Lactamase Inhibitor
    Publication number: 20160289245
    Abstract: A crystalline compound of formula (I): The compound of formula (I) is a ?-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 6, 2016
    Applicant: Allecra Therapeutics SAS
    Inventors: Alessandro Lamonica, Marco Forzatti, Stefano Biondi